- Filed
- May 9, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 1, 2025 | 8.93M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 8.57M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 8.08M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $1.03M |
| Capex | Q1 2025 · Mar 31, 2024 | $64K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$21.05M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$48.72M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $207.4M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $202.61M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $1M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $2M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $7M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $9.87M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $138.1M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $83.3M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | −$1.36B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$1.36B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$1.26B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$1.26B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.06B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $710.23M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $1.29B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $930.49M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $788.21M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $434.65M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $895.68M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $544.38M |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$2.90 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$3.53 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$2.90 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$3.53 |
| Net Income | Q1 2025 · Mar 31, 2025 | −$11.74M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$15.91M |
| Operating Income | Q1 2025 · Mar 31, 2025 | $2.66M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$23.1M |